Evidence map›Paper›PMID 31354905›Full record

ArticleOxidative medicine and cellular longevity2019

Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.

Ran Li, Yuan Liu, Ying-Guang Shan, Lu Gao, Fang Wang, Chun-Guang Qiu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Evaluation the protective role of baicalin against HFrontiers in veterinary science · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  13. Ononin alleviates HExperimental and therapeutic medicine · 2021
    Article
  14. Review
  15. Review
  16. FGF1Signal transduction and targeted therapy · 2021
    Article
  17. Review
  18. Enhancing Fatty Acids OxidationFrontiers in pharmacology · 2021
    Article
  19. Role of Nrf2 in cell senescence regulation.Molecular and cellular biochemistry · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ran LiDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, China.ORCID https://orcid.org/0000-0003-2877-2582
Yuan LiuDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, China.ORCID https://orcid.org/0000-0003-3521-6410
Ying-Guang ShanDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, China.
Lu GaoDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, China.
Fang WangDepartment of Endocrinology, The First Affiliated Hospital of Zhengzhou University, China.ORCID https://orcid.org/0000-0002-7474-9263
Chun-Guang QiuDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, China.ORCID https://orcid.org/0000-0001-6857-8974
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies demonstrated that Bailcalin (BAI) prevented cardiac injuries under different disease models. Whether BAI protected against type 2 diabetes mellitus- (T2DM-) associated cardiomyopathy was investigated in this study. T2DM was established by the combination of streptozotocin injection and high-fat diet in mice. BAI was administered daily for 6 months. After evaluating cardiac functions, mice hearts were removed and processed for morphological, biochemical, and molecular mechanism analyses. Neonatal rat cardiomyocytes (NRCM) were isolated and treated with high glucose and palmitate (HG/Pal) for

Indexed as

AMP-Activated Protein KinasesAnimalsAntioxidantsDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDisease Models, AnimalKelch-Like ECH-Associated Protein 1MaleMiceMice, Inbred C57BLNF-E2-Related Factor 2ThioglucosidesTransfectionAMP-Activated Protein KinasesAntioxidantsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Thioglucosides

Identifiers

PMID31354905
PMCPMC6636513
OpenAlexW2956067100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.